Sutro Biopharma Inc
Sutro Biopharma Inc (STRO) Implied Volatility Current
STRO implied volatility is 112%. IV Rank is 16%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking STRO implied volatility helps you identify when options premiums on Sutro Biopharma Inc are historically cheap or expensive, and where the best trades are hiding. Sutro Biopharma Inc implied volatility reflects the market's expectation of future price movement: when STRO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Sutro Biopharma Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For STRO, tracking metrics like STRO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on STRO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials.
It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where STRO implied volatility sits today versus where it has been. Our scanner ranks Sutro Biopharma Inc implied volatility against its historical range, surfaces extremes in STRO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Sutro Biopharma Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 16, 2026
Trade options with IV on your side
Track STRO IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→